Proceedings of the 12th annual deep brain stimulation think tank: cutting edge technology meets novel applications.
Proceedings of the 12th annual deep brain stimulation think tank: cutting edge technology meets novel applications.
Where did the research take place?
The study site has not been established. Author addresses may differ from where the research occurred.
Norman, US · Author affiliation
Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL, United States.Location evidence
Atlanta, US · Author affiliation
School of Electrical and Computer Engineering, Georgia Institute of Technology, Atlanta, GA, United States.Location evidence
San Francisco, US · Author affiliation
Movement Disorders and Neuromodulation Centre, University of California San Francisco, San Francisco, CA, United States.Location evidence
Oxford, GB · Author affiliation
Medical Research Council Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.Location evidence
Durham, US · Author affiliation
Departments of Biomedical Engineering, Electrical and Computer Engineering, Neurobiology and Neurosurgery, Duke University and Duke University Medical Center, Durham, NC, United States.Location evidence
US · Author affiliation · country only
Center for Neurological Restoration, Cleveland Clinic, Cleveland, OH, United States.Location evidence
New York City, US · Author affiliation
Weill Cornell Medical College, Feil Family Brain and Mind Research Institute, New York, NY, United States.Location evidence
Minneapolis, US · Author affiliation
Restorative Therapies Group Implantables, Research, and Core Technology, Medtronic Inc., Minneapolis, MN, United States.Location evidence
Los Angeles, US · Author affiliation
Department of Neurosurgery, University of California, Los Angeles, CA, United States.Location evidence
Boston, US · Author affiliation
Boston Scientific Neuromodulation, Valencia, CA, United States.Location evidence
Valencia, US · Author affiliation
Boston Scientific Neuromodulation, Valencia, CA, United States.Location evidence
Plano, US · Author affiliation
Neuromodulation Division, Abbott, Plano, TX, United States.Location evidence
Mountain View, US · Author affiliation
NeuroPace, Inc., Mountain View, CA, United States.Location evidence
Milan, IT · Author affiliation
Newronika SpA, Milan, Italy.Location evidence
Morgantown, US · Author affiliation
West Virginia University, Morgantown, WV, United States.Location evidence
Houston, US · Author affiliation
Department of Bioengineering, Rice University, Houston, TX, United States.Location evidence
Düsseldorf, DE · Author affiliation
Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.Location evidence
London, GB · Author affiliation
Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, London, United Kingdom.Location evidence
Toronto, CA · Author affiliation
Clinical and Computational Neuroscience, Krembil Research Institute, University Health Network, Toronto, ON, Canada.Location evidence
Tübingen, DE · Author affiliation
Faculty of Medicine, Institute for Neuromodulation and Neurotechnology, University Hospital Tübingen (UKT), University Tübingen, Tübingen, Germany.Location evidence
Hopkins, US · Author affiliation
Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, United States.Location evidence
Baltimore, US · Author affiliation
Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, United States.Location evidence
Philadelphia, US · Author affiliation
Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA, United States.Location evidence
St. Louis, US · Author affiliation
Department of Neurology, Washington University School of Medicine, St. Louis, MO, United States.Location evidence
Changping, CN · Author affiliation
Changping Laboratory, Beijing, China.Location evidence
Beijing, CN · Author affiliation
Changping Laboratory, Beijing, China.Location evidence
Maastricht, NL · Author affiliation
School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands.Location evidence
Aachen, DE · Author affiliation
Department of Neurosurgery, RWTH Aachen University Hospital, Aachen, Germany.Location evidence
A plain-language reading has not been prepared for this paper yet.
Original abstract
The Deep Brain Stimulation (DBS) Think Tank XII was held on August 21st to 23rd. This year we showcased groundbreaking advancements in neuromodulation technology, focusing heavily on the novel uses of existing technology as well as next-generation technology. Our keynote speaker shared the vision of using neuro artificial intelligence to predict depression using brain electrophysiology. Innovative applications are currently being explored in stroke, disorders of consciousness, and sleep, while established treatments for movement disorders like Parkinson's disease are being refined with adaptive stimulation. Neuromodulation is solidifying its role in treating psychiatric disorders such as depression and obsessive-compulsive disorder, particularly for patients with treatment-resistant symptoms. We estimate that 300,000 leads have been implanted to date for neurologic and neuropsychiatric indications. Magnetoencephalography has provided insights into the post-DBS physiological changes. The field is also critically examining the ethical implications of implants, considering the long-term impacts on clinicians, patients, and manufacturers.